chevron_leftBack
As of 14 June 2026, Lumos Diagnostics Holdings Ltd. has a market cap of $97.29M USD, ranking #25759 globally and #589 in Australia.
It ranks #2304 in the Healthcare sector, and #477 in the Medical Devices industry.
Key Stats
Market Cap
$97.29MUSD
138.4M AUD
Enterprise Value
$101.18MUSD
143.62M AUD
Revenue (TTM)
$12.87MUSD
18.31M AUD
EBITDA (TTM)
-$11.17MUSD
-15.86M AUD
Net Income (TTM)
-$9.76MUSD
-13.88M AUD
EBITDA Margin
-87%
Profit Margin
-76%
Forward PE
0.2
PS Ratio
7.6
PB Ratio
17.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Douglas Ward
open_in_new
Founded
2018
Website
lumosdiagnostics.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 10% | -14% | -41% | -23% | -25% | 477% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
LDX
Lumos Diagnostics Holdings Ltd Ordinary Shares
ISIN: AU0000157091
Shares Out.:
Shares Outstanding:
929.211M1
Shares Float:
562.455M2
|
0.1650 AUD | |
|
LDXHF
Lumos Diagnostics Holdings Ltd Ordinary Shares
ISIN: AU0000157091
Shares Out.:
Shares Outstanding:
748.523M1
Shares Float:
527.224M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0800 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
ASX: COH
|
$4.14B
4K%
5.89B AUD
|
17.1
|
|
NZE: EBO
|
$2.53B
2K%
4.34B NZD
|
16.0
|
|
ASX: CU6
|
$774.53M
696%
1.1B AUD
|
-
|
|
ASX: NAN
|
$731.96M
652%
1.04B AUD
|
52.3
|
|
ASX: TTX
|
$168.43M
73%
239.61M AUD
|
-
|
|
ASX: OCC
|
$167.82M
73%
238.75M AUD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
178K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
165K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
163K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
130K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
124K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
105K%
|
22.2
|
chevron_leftBack